Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis. [electronic resource]
Producer: 20120405Description: 43-51 p. digitalISSN:- 1872-8421
- Analysis of Variance
- Animals
- Cytokines -- metabolism
- Disease Models, Animal
- Encephalomyelitis, Autoimmune, Experimental -- chemically induced
- Female
- Gene Expression Regulation -- drug effects
- Glial Fibrillary Acidic Protein -- metabolism
- Glycoproteins -- toxicity
- Hyperalgesia -- drug therapy
- Immunosuppressive Agents -- therapeutic use
- Mice
- Mice, Inbred C57BL
- Myelin Basic Protein -- genetics
- Myelin Sheath -- metabolism
- Myelin-Oligodendrocyte Glycoprotein
- Neuralgia -- drug therapy
- Pain Threshold -- drug effects
- Peptide Fragments -- toxicity
- Pertussis Toxin -- toxicity
- RNA, Messenger -- metabolism
- Sirolimus -- therapeutic use
- T-Lymphocytes -- drug effects
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.